IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS - Report - MDSpire

IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS

  • By

  • Veronica Buia

  • Cecilia Catellani

  • Stefania Croci

  • Beatrice Righi

  • Daria Morini

  • Angela Immacolata Falbo

  • Alessia Nicoli

  • Alessandro De Fanti

  • Lucia Belloni

  • Lorenzo Aguzzoli

  • Maria Teresa Villani

  • Chiara Sartori

  • Maria Elisabeth Street

  • June 5, 2026

  • 0 min

Share

Alterations in Follicular Fluid Levels of IGF-II, IGFBP-4, -6, -7, and HMGB1 in Patients with Polycystic Ovary Syndrome

Overview

This study investigates the concentrations of IGF system proteins in follicular fluid from women with polycystic ovary syndrome (PCOS) compared to controls. Key findings include lower levels of IGF-II and IGFBP-4, and increased levels of IGFBP-6 and IGFBP-7 in PCOS patients.

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, associated with various metabolic and reproductive complications. The IGF system plays a role in ovarian function and glucose metabolism, and its alteration in PCOS may contribute to the disease's pathophysiology.

Data Highlights

ProteinPCOSControls
IGF-IILowerHigher
IGFBP-4LowerHigher
IGFBP-6HigherLower
IGFBP-7HigherLower
HMGB1IncreasedNormal

Key Findings

  • Lower levels of IGF-II and IGFBP-4 in follicular fluid from PCOS patients compared to controls.
  • Increased levels of IGFBP-6 and IGFBP-7 in PCOS patients.
  • Similar levels of IGF-I and IGFBP-1, -2, and -3 between PCOS and controls.
  • HMGB1 levels were increased in the follicular fluid of PCOS patients.
  • Correlation between HMGB1 and IGFBP-2 in PCOS, indicating a link to inflammation.
  • Bioavailability of IGF-II was significantly lower in PCOS patients.

Clinical Implications

The alterations in IGF system proteins in follicular fluid may reflect impaired follicular development in PCOS. These findings could inform future research directions and enhance understanding of the metabolic dysfunctions associated with PCOS.

Conclusion

The study reveals significant alterations in IGF system proteins in PCOS, which may contribute to the understanding of the disease's pathophysiology. Further research is warranted to explore the implications of these findings.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. International Evidence-based, 2023 -- Evidence-based Guidelines for the Assessment and Management of PCOS
  6. A Systematic Review of Inflammatory Markers in PCOS, PMC -- Meta-Analysis of Interleukin-6 (IL-6)
  7. International Evidence-based
  8. A Systematic Review of Inflammatory Markers in Polycystic Ovary Syndrome (PCOS) and Meta-Analysis of Interleukin-6 (IL-6) in Case-Control Studies - PMC

Original Source(s)

Related Content